- Home
- ILMN vs HUBB Comparison
ILMN vs HUBB Comparison
Compare ILMN & HUBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- HUBB
- Stock Information
- Founded
- ILMN 1998
- HUBB 1888
- Country
- ILMN United States
- HUBB United States
- Employees
- ILMN N/A
- HUBB N/A
- Industry
- ILMN Medical Specialities
- HUBB Industrial Machinery/Components
- Sector
- ILMN Health Care
- HUBB Technology
- Exchange
- ILMN Nasdaq
- HUBB Nasdaq
- Market Cap
- ILMN 15.9B
- HUBB 19.0B
- IPO Year
- ILMN 2000
- HUBB N/A
- Fundamental
- Price
- ILMN $81.88
- HUBB $341.62
- Analyst Decision
- ILMN Buy
- HUBB Hold
- Analyst Count
- ILMN 18
- HUBB 8
- Target Price
- ILMN $141.94
- HUBB $462.13
- AVG Volume (30 Days)
- ILMN 2.2M
- HUBB 691.6K
- Earning Date
- ILMN 05-01-2025
- HUBB 04-29-2025
- Dividend Yield
- ILMN N/A
- HUBB 1.56%
- EPS Growth
- ILMN N/A
- HUBB 2.28
- EPS
- ILMN N/A
- HUBB 14.37
- Revenue
- ILMN $4,372,000,000.00
- HUBB $5,628,500,000.00
- Revenue This Year
- ILMN $0.69
- HUBB $6.44
- Revenue Next Year
- ILMN $4.91
- HUBB $5.26
- P/E Ratio
- ILMN N/A
- HUBB $23.16
- Revenue Growth
- ILMN N/A
- HUBB 4.76
- 52 Week Low
- ILMN $77.54
- HUBB $316.34
- 52 Week High
- ILMN $156.66
- HUBB $481.35
- Technical
- Relative Strength Index (RSI)
- ILMN 35.35
- HUBB 43.79
- Support Level
- ILMN $77.54
- HUBB $316.34
- Resistance Level
- ILMN $89.95
- HUBB $355.34
- Average True Range (ATR)
- ILMN 2.91
- HUBB 9.46
- MACD
- ILMN 0.63
- HUBB 1.80
- Stochastic Oscillator
- ILMN 34.97
- HUBB 64.82
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About HUBB Hubbell Inc
Hubbell is a diversified conglomerate industrial company that mostly competes in the electrical components market. Its products and services serve vital portions of the U.S. electrical supply chain, including transmission and distribution as well as the commercial, industrial, and residential end markets. The company organizes its business into two segments: Utility Solutions Segment and the Electrical Solutions Segment. It derives maximum revenue from Utility Solutions Segment.